Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve analysts that are currently covering the company, Marketbeat ...

BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, Ratings reports. The brokerage issued an outperform ...

Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today... Investing.com -- The S&P 500 closed slightly higher ...

On Wednesday, Stifel analysts reiterated their Buy rating and $27.00 price target for Rocket Lab USA (NASDAQ:RKLB) shares, which ...

Rocket Lab USA, Inc. (RKLB) shares were trading more than 5% higher after-hours following the company’s reported Q1 results, with... Rocket Lab USA, Inc. (RKLB) reported Q1 EPS of ($0.06), $0.02 worse ...

Rocket Lab USA has a jam-packed 2025 schedule filled with new launches as well as acquisitions. Check out why I'm initiating ...

Every day, one stock rises to the top. Which one is leading today? Rocket Lab USA, Inc. RKLB shares are trading higher on Wednesday following significant announcements in the satellite and ...

Shares of Laser Photonics Corporation are rising after the company secured a major order from Rocket Lab USA. Rocket Lab will ...